Rock Springs Capital Management LP Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$4.2B
Holdings
120
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (120 positions)
| Stock | Value |
|---|---|
GOSS 5 06/01/27GOSSAMER BIO INC | $3.0B |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $1.0B |
LPTXEURLEAP THERAPEUTICS INC | $1.0B |
IMCRIMMUNOCORE HLDGS PLC | $189.0M |
PODDINSULET CORP | $154.0M |
NBIXNEUROCRINE BIOSCIENCES INC | $134.0M |
ARGXARGENX SE | $132.0M |
AGLAGILON HEALTH INC | $127.0M |
PENPENUMBRA INC | $113.0M |
RXDXPROMETHEUS BIOSCIENCES INC | $113.0M |
EVHEVOLENT HEALTH INC | $106.0M |
MDGLMADRIGAL PHARMACEUTICALS INC | $101.0M |
AGIOAGIOS PHARMACEUTICALS INC | $84.0M |
IDXXIDEXX LABS INC | $84.0M |
HZNPHORIZON THERAPEUTICS PUB L | $84.0M |
2L9BLUEPRINT MEDICINES CORP | $82.0M |
KRTXKARUNA THERAPEUTICS INC | $81.0M |
ISRGINTUITIVE SURGICAL INC | $79.0M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $79.0M |
ALNYALNYLAM PHARMACEUTICALS INC | $79.0M |
AKROAKERO THERAPEUTICS INC | $76.0M |
ACHCACADIA HEALTHCARE COMPANY IN | $69.0M |
AFWALIGN TECHNOLOGY INC | $63.0M |
ACRSACLARIS THERAPEUTICS INC | $62.0M |
RAREULTRAGENYX PHARMACEUTICAL IN | $59.0M |
BAXBAXTER INTL INC | $58.0M |
SRPTSAREPTA THERAPEUTICS INC | $56.0M |
DC4DEXCOM INC | $55.0M |
ASNDASCENDIS PHARMA A/S | $51.0M |
SGENUSDSEAGEN INC | $51.0M |
RYTMRHYTHM PHARMACEUTICALS INC | $51.0M |
EWEDWARDS LIFESCIENCES CORP | $48.0M |
XENEXENON PHARMACEUTICALS INC | $46.0M |
PRTAPROTHENA CORP PLC | $45.0M |
AMLXAMYLYX PHARMACEUTICALS INC | $45.0M |
EXASEXACT SCIENCES CORP | $43.0M |
WSTWEST PHARMACEUTICAL SVSC INC | $43.0M |
PHRPHREESIA INC | $42.0M |
NVROEURNEVRO CORP | $42.0M |
PCRXPACIRA BIOSCIENCES INC | $39.0M |
—OLINK HLDG AB | $36.0M |
MRTXEURMIRATI THERAPEUTICS INC | $36.0M |
MIRMMIRUM PHARMACEUTICALS INC | $35.0M |
FRPTFRESHPET INC | $34.0M |
—ABCAM PLC | $33.0M |
ZLABZAI LAB LTD | $32.0M |
KYMRKYMERA THERAPEUTICS INC | $30.0M |
IRTCIRHYTHM TECHNOLOGIES INC | $28.0M |
XLVSELECT SECTOR SPDR TR | $27.0M |
BMRNBIOMARIN PHARMACEUTICAL INC | $27.0M |
CMPXCOMPASS THERAPEUTICS INC | $26.0M |
—MERSANA THERAPEUTICS INC | $24.0M |
SWAVUSDSHOCKWAVE MED INC | $23.0M |
LEGNLEGEND BIOTECH CORP | $22.0M |
BCRXBIOCRYST PHARMACEUTICALS INC | $21.0M |
TVTXTRAVERE THERAPEUTICS INC | $20.0M |
AZTAAZENTA INC | $20.0M |
CYTKCYTOKINETICS INC | $20.0M |
NUVB/WSNUVATION BIO INC | $19.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $19.0M |
IMTXIMMATICS N.V | $19.0M |
TCE2CELLDEX THERAPEUTICS INC NEW | $18.0M |
CNMDCONMED CORP | $18.0M |
ANABANAPTYSBIO INC | $17.0M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $16.0M |
WRBYWARBY PARKER INC | $16.0M |
ACCDEURACCOLADE INC | $15.0M |
LFSTLIFESTANCE HEALTH GROUP INC | $13.0M |
—CINCOR PHARMA INC | $13.0M |
290ACHINOOK THERAPEUTICS INC | $13.0M |
AM6AMICUS THERAPEUTICS INC | $12.0M |
AURAAURA BIOSCIENCES INC | $10.0M |
RLAYRELAY THERAPEUTICS INC | $10.0M |
VERVVERVE THERAPEUTICS INC | $10.0M |
NVCRNOVOCURE LTD | $9.0M |
HCATHEALTH CATALYST INC | $9.0M |
—AMRYT PHARMA PLC | $9.0M |
BHVNBIOHAVEN LTD | $9.0M |
EDAEDAP TMS S A | $9.0M |
MGNXMACROGENICS INC | $7.0M |
—ICOSAVAX INC | $6.0M |
IRONDISC MEDICINE INC | $6.0M |
BMEABIOMEA FUSION INC | $6.0M |
LUNGPULMONX CORP | $5.0M |
GHGUARDANT HEALTH INC | $5.0M |
NVV1NOVAVAX INC | $5.0M |
VIGLVIGIL NEUROSCIENCE INC | $5.0M |
NVTA1EURINVITAE CORP | $5.0M |
—GAMIDA CELL LTD | $5.0M |
—F-STAR THERAPEUTICS INC | $4.0M |
BEAMBEAM THERAPEUTICS INC | $4.0M |
MREOMEREO BIOPHARMA GROUP PLC | $4.0M |
KNTEKINNATE BIOPHARMA INC | $4.0M |
DSGNDESIGN THERAPEUTICS INC | $4.0M |
TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | $3.0M |
XLOXILIO THERAPEUTICS INC | $3.0M |
ALTALTIMMUNE INC | $3.0M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $3.0M |
INZYINOZYME PHARMA INC | $3.0M |
—PARATEK PHARMACEUTICALS INC | $3.0M |
Page 1 of 2Next